Sihuan Pharmaceutical Holdings Group Ltd. (HKG: 0460)

Sihuan Pharmaceutical Holdings Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4,010	3,779	3,829	5,682	4,604	5,117
Trading Asset Securities	854.39	589.02	962.99	109.3	332.68	148.34
Cash & Short-Term Investments	4,864	4,368	4,792	5,792	4,937	5,265
Cash Growth	7.86%	-8.85%	-17.26%	17.32%	-6.24%	14.02%
Accounts Receivable	537.72	397.82	522.25	779.07	389.82	292.2
Other Receivables	258.49	262.32	342.67	100.36	317.66	141.67
Receivables	1,253	1,045	977.61	1,094	820.92	513.19
Inventory	475.41	557.32	606.7	715.3	495.89	409.6
Other Current Assets	147.23	233.61	174.23	140.09	150.62	116.88
Total Current Assets	6,740	6,204	6,550	7,741	6,404	6,305
Property, Plant & Equipment	2,782	2,842	2,998	4,093	3,841	3,625
Long-Term Investments	747.26	1,004	907.34	972.53	1,267	1,258
Goodwill	1.85	1.85	1.85	14.17	12.31	-
Other Intangible Assets	801.5	655.52	594.1	445.8	310.92	285.23
Long-Term Deferred Tax Assets	26.38	31.77	96.77	303.46	269.45	332.22
Long-Term Deferred Charges	-	120.44	32.36	164.3	194.7	194.78
Other Long-Term Assets	427.95	359.63	393.46	393.84	400.82	348.96
Total Assets	11,527	11,535	12,141	14,496	13,044	12,571
Accounts Payable	215.87	220.61	205.78	118.91	106.2	65.72
Accrued Expenses	459.64	504.92	700.08	1,077	986.09	1,209
Short-Term Debt	5.46	-	25.8	30	283.29	-
Current Portion of Long-Term Debt	222.06	269.68	315.17	170	108.64	-
Current Portion of Leases	11.47	24.5	21.3	5.19	1.44	4.06
Current Income Taxes Payable	37.22	44.21	67.86	111.25	22.45	14.03
Current Unearned Revenue	174.26	143.05	175.92	214.11	197.11	336.9
Other Current Liabilities	2,990	2,900	1,021	775.11	737.87	631.35
Total Current Liabilities	4,116	4,107	2,533	2,502	2,443	2,261
Long-Term Debt	859.23	905.03	848.67	844.75	359.17	9
Long-Term Leases	26.68	51.98	79.94	31.46	2.51	5.89
Long-Term Unearned Revenue	37.16	163.28	135.81	82.34	64.74	70.95
Long-Term Deferred Tax Liabilities	70.39	70.32	99.04	222.39	225.69	282.62
Other Long-Term Liabilities	1,328	1,101	2,804	1,663	-	-
Total Liabilities	6,437	6,398	6,501	5,346	3,095	2,629
Common Stock	77.06	77.06	77.06	77.06	78.19	78.19
Additional Paid-In Capital	3,882	3,882	3,882	3,882	4,085	4,085
Retained Earnings	897.51	1,336	1,691	4,922	4,628	5,575
Treasury Stock	-47.7	-33.81	-	-	-	-
Comprensive Income & Other	-387.96	-829.01	-913.86	-597.15	398.83	-131.3
Total Common Equity	4,421	4,432	4,737	8,284	9,190	9,607
Minority Interest	668.06	704.89	902.83	865.92	758.38	335.51
Shareholders' Equity	5,089	5,137	5,640	9,150	9,949	9,942
Total Liabilities & Equity	11,527	11,535	12,141	14,496	13,044	12,571
Total Debt	1,125	1,251	1,291	1,081	755.05	18.95
Net Cash (Debt)	3,740	3,116	3,501	4,710	4,182	5,247
Net Cash Growth	17.56%	-10.98%	-25.67%	12.64%	-20.30%	15.99%
Net Cash Per Share	0.40	0.34	0.38	0.50	0.44	0.55
Filing Date Shares Outstanding	9,320	9,282	9,330	9,330	9,466	9,466
Total Common Shares Outstanding	9,320	9,282	9,330	9,330	9,466	9,466
Working Capital	2,624	2,097	4,017	5,240	3,961	4,044
Book Value Per Share	0.47	0.48	0.51	0.89	0.97	1.01
Tangible Book Value	3,618	3,775	4,141	7,824	8,867	9,321
Tangible Book Value Per Share	0.39	0.41	0.44	0.84	0.94	0.98
Buildings	-	3,539	3,596	2,956	2,763	2,582
Machinery	-	1,572	1,505	1,288	1,147	926.27
Construction In Progress	-	295.53	346.87	819.92	680.28	559.09

Source: S&P Capital IQ. Standard template. Financial Sources.